{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:58:38Z","timestamp":1793336318164,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018262","name":"Intercept Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002711","name":"California Dental Association Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018952","name":"Birmingham Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020406","name":"Dr. Falk Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010311","name":"Guts UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008538","name":"PSC Partners Seeking a Cure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cgh.2021.08.039","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T11:33:27Z","timestamp":1630323207000},"page":"1687-1700.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies"],"prefix":"10.1016","volume":"20","author":[{"given":"Palak J.","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kidist K.","family":"Yimam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homie","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2367-6535","authenticated-orcid":false,"given":"Chris","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2021.08.039_bib1","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.08.039_bib2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/00365521.2015.1036359","article-title":"Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013","volume":"50","author":"Fosby","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.039_bib3","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S0168-8278(20)31043-6","article-title":"Projection of liver transplant activity per indication in France and United Kingdom","volume":"73","author":"Connolly","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2017.06.027","article-title":"Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis","volume":"67","author":"Trivedi","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2468-1253(20)30005-4","article-title":"Colorectal cancer in Crohn\u2019s disease: a Scandinavian population-based cohort study","volume":"5","author":"Ol\u00e9n","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel diseases, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.08.039_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007116","article-title":"Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.cgh.2021.08.039_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-021-10214-6","article-title":"Increased risk of cancer in patients with primary sclerosing cholangitis","author":"Lundberg B\u00e5ve","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2021.08.039_bib9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.30509","article-title":"The nonsteroidal farnesoid X receptor agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with primary sclerosing cholangitis","volume":"70","author":"Trauner","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.08.039_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A\u00a0randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73","author":"Kowdley","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib11","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.28991","article-title":"New therapeutic concepts in bile acid transport and signaling for management of cholestasis","volume":"65","author":"Trauner","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.08.039_bib12","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.08.039_bib13","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.3390\/ijerph17093095","article-title":"Primary sclerosing cholangitis: burden of disease and mortality using data from the national rare diseases registry in Italy","volume":"17","author":"Carbone","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cgh.2021.08.039_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.039_bib15","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.039_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00535-020-01663-1","article-title":"An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort","volume":"55","author":"Bakhshi","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.039_bib17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","article-title":"Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study","volume":"48","author":"Card","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1440-1746.2002.02835.x","article-title":"Clinical profile of primary sclerosing cholangitis in Singapore","volume":"17","author":"Ang","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cgh.2020.05.061","article-title":"Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis","volume":"19","author":"Lamba","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.08.039_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.039_bib22","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.08.039_bib23","first-page":"371","article-title":"[Primary sclerosing cholangitis in Iceland 1992-2012]","volume":"105","author":"Gudnason","year":"2019","journal-title":"Laeknabladid"},{"key":"10.1016\/j.cgh.2021.08.039_bib24","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.08.039_bib25","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.039_bib26","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population","volume":"11","author":"Toy","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.039_bib28","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.cgh.2021.01.029","article-title":"The epidemiology of UK autoimmune liver disease varies with geographic latitude","volume":"19","author":"Webb","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.hepres.2004.03.006","article-title":"Analysis of 388 cases of primary sclerosing cholangitis in Japan. Presence of a subgroup without pancreatic involvement in older patients","volume":"29","author":"Takikawa","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2021.08.039_bib30","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2021.08.039_bib31","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.08.039_bib32","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/liv.14645","article-title":"Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis","volume":"40","author":"Culver","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.08.039_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort","volume":"32","author":"de Valle","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.08.039_bib35","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline","volume":"49","author":"Aabakken","year":"2017","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2021.08.039_bib36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG Clinical Guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.039_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-2007-1007179","article-title":"The geoepidemiology of primary biliary cirrhosis","volume":"17","author":"Metcalf","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2021.08.039_bib38","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.08.039_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2468-1253(19)30013-5","article-title":"Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development","volume":"4","author":"King","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.039_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15008","article-title":"Racial differences in primary sclerosing cholangitis mortality is associated with community socioeconomic status","author":"Are","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.08.039_bib42","first-page":"4517","article-title":"Incidence and prevalence of autoimmune liver diseases","volume":"118","author":"Berdal","year":"1998","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.cgh.2021.08.039_bib43","first-page":"813","article-title":"Clinical hepatology: profile of an urban, hospital-based practice","volume":"24","author":"Byron","year":"1996","journal-title":"Hepatology"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521009198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521009198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:40:03Z","timestamp":1761543603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356521009198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1542356521009198"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2021.08.039","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2021.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}